PFM Health Sciences’s Treace Medical Concepts TMCI Stock Holding History

PFM Health Sciences’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50,000	Closed	-$123K	–	100
2025 Q4	$123K	Buy	+50,000	New	+$217K	0.01%	78

Other funds holding TMCI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CBU

CIBC Bancorp USA Chicago, Illinois $74.4B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PFM Health Sciences's TMCI Position: Q1 2026 in Review

PFM Health Sciences sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 50,000 shares — an estimated $123K sold.

PFM Health Sciences first reported a position in TMCI in Q4 2025 and held it in 1 quarter. The position peaked at $123K in Q4 2025. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

PFM Health Sciences reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
PFM Health Sciences sold 50,000 Treace Medical Concepts shares in Q1 2026, an estimated $123K.
PFM Health Sciences first reported a position in Treace Medical Concepts in Q4 2025 and held it in 1 quarter.
PFM Health Sciences's Treace Medical Concepts position peaked at $123K in Q4 2025.
118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.